Strain-dependent suppressive effects of BCG vaccination on asthmatic reactions in BALB/c mice

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 6, 2005, Pages 571-578

  Choi, Inseon S ^a   Lin, Xiang Hua ^a,b   Koh, Young Ah ^b   Koh, Youngil I ^a,b   Lee, Hyun Chul ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Research Institute of Medical Sciences   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; METHACHOLINE; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BCG VACCINATION; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; FEMALE; INFLAMMATORY CELL; LUNG FUNCTION TEST; LUNG LAVAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SPLEEN CELL; TH1 CELL; TH2 CELL;

EID: 29444432775     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61021-6     Document Type: Article

References (25)

1. Cameron L, Vercelli D. Synthesis and regulation of immunoglobulin E. In: Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, eds. Middleton's Allergy Principles & Practice. 6th ed. Philadelphia, PA: Mosby Inc; 2003:87-100.
2. Umetsu DT, Akbari O, DeKruyff RH. Regulatory T cells control the development of allergic disease and asthma. J Allergy Clin Immunol. 2003;112:480-487.
3. Choi IS, Koh YI. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann Allergy Asthma Immunol. 2002;88:584-591.
4. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol. 2001;107:531-534.
5. Shirtcliffe PM, Easthope SE, Cheng S, et al. The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. Am J Respir Crit Care Med. 2001;163:1410-1414.
6. Lagranderie MR, Balazuc AM, Deriaud E, et al. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun. 1996;64:1-9.
7. Krishna MT, Salvi SS. Could administration of BCG vaccination at birth protect from the development of asthma and allergic diseases in the western world? Has this question been adequately investigated? Pediatr Allergy Immunol. 2002;13:172-176.
8. Hopfenspirger MT, Agrawal DK. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol. 2002;168:2516-2522.
9. Sterk PJ. Bronchoconstrictor dose-response curves. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, eds. Asthma. Philadelphia, PA: Lippincott-Raven Publishers; 1997:1267-1275.
10. Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997;159:1739-1745.
11. Erb KJ, Holloway JW, Sobeck A, et al. Infection of mice with Mycobacterium bovis-bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med. 1998;187:561-569.
12. Herz U, Gerhold K, Gruber C, et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol. 1998;102;867-874.
13. Shehadeh N, Calcinaro F, Bradley BJ, et al. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet. 1994;343:706-707,
14. Yoshida M, Leigh R, Matsumoto K, et al. Effect of interferon-γ on allergic airway responses in interferon-γ-deficient mice. Am J Respir Crit Care Med. 2002;166:451-456.
15. Huang TJ, MacAry PA, Eynott P, et al. Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-γ. J Immunol. 2001;166:207-217,
16. Cohn L, Ray A. Biology of lymphocytes. In: Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, eds. Middleton's Allergy Principles & Practice. 6th ed. Philadelphia, PA: Mosby Inc; 2003:279-290.
17. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest. 1999;103:175-183.
18. El Biaze M, Boniface S, Koscher V, et al. T cell activation, from atopy to asthma: more a paradox than a paradigm. Allergy. 2003;58:844-853.
19. Shi HZ, Xiao CQ, Zhong D, et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med. 1998;157:204-209.
20. Fernandez-Botran R, Sanders VM, Mosmann TR, Vitetta ES, Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J Exp Med. 1988;168:543-558.
21. Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000;356:2144-2148.
22. Alm JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet. 1997;350:400-403.
23. Nahori MA, Lagranderie M, Lefort J, et al. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine. 2001;19:1484-1495.
24. Saint F, Patard JJ, Irani J, et al. Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer. Urology. 2001;57:617-621.
25. Appelberg R. Mycobacterial infection primes T cells and macrophages for enhanced recruitment of neutrophils. J Leukoc Biol. 1992;51:472-477.